Literature DB >> 7235994

Metabolic activation of drugs in mutagenicity tests in vitro.

M B Roberfroid.   

Abstract

The metabolic pathways of chemical compounds of pharmaceutical interest are reviewed in relation to the role of activation and detoxification in the process of mutagenicity. The properties and subcellular localization of the enzymes involved are given together with the main reactions they catalyze. The role of metabolism in mutagenicity testing in vitro is discussed with special emphasis on the choice of the enzymatic system. Parameters such as species, strain, sex, diet, and induction are considered. The effect of various enzymatic effectors added in vitro is also discussed. It is concluded that the metabolism of drugs is very complex, involving both activation and detoxification processes catalyzed by a large variety of enzymes. Production of mutations in vitro in prokaryotic or eukaryotic cells is the results of a balance between all those pathways. Metabolic activation thus merits special attention.

Mesh:

Substances:

Year:  1980        PMID: 7235994     DOI: 10.1007/bf00361256

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  31 in total

1.  IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some miscellaneous pharmaceutical substances.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Man       Date:  1977

2.  Biological implications of the reaction possibilities of the proximate carcinogenic compound, N-hydroxy-2-fluorenylacetamide.

Authors:  G Lhoëst; C Razzouk; M Mercier
Journal:  Biomed Mass Spectrom       Date:  1976-02

3.  The development of a "Microtitre" fluctuation test for the detection of indirect mutagens, and its use in the evaluation of mixed enzyme induction of the liver.

Authors:  D G Gatehouse; G F Delow
Journal:  Mutat Res       Date:  1979-05       Impact factor: 2.433

4.  7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver.

Authors:  M K Buening; J G Fortner; A Kappas; A H Corney
Journal:  Biochem Biophys Res Commun       Date:  1978-05-15       Impact factor: 3.575

Review 5.  Novel pathways in drug metabolism.

Authors:  P Jenner; B Testa
Journal:  Xenobiotica       Date:  1978-01       Impact factor: 1.908

6.  Oxidative drug metabolism in human liver microsomes.

Authors:  E B Nelson; P P Raj; K J Belfi; B S Masters
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

7.  Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains.

Authors:  H Bartsch; C Malaveille; R Montesano
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

8.  Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver.

Authors:  K Ota; B D Hammock
Journal:  Science       Date:  1980-03-28       Impact factor: 47.728

9.  Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources.

Authors:  J P Brown; P S Dietrich
Journal:  Mutat Res       Date:  1979-03       Impact factor: 2.433

10.  In vivo and in vitro effects of 3-methylcholanthrene on the microsome-mediated in vitro mutagenicity of 2-acetylaminofluorene.

Authors:  M Batardy-Gregoire; C Razzouk; E Agazzi-Leonard; M Mercier; F Poncelet; M Roberfroid
Journal:  Toxicol Lett       Date:  1981-03       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.